Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Kazuhiro Kozawa"'
Publikováno v:
Journal of Oncology Pharmacy Practice. 19:190-192
Autor:
Kazuhiro Kozawa, Takuo Ito, Akiko Kimura, Takayoshi Kiba, Yoshikazu Ogawa, Hiromasa Niimi, Atsuko Hosokawa, Yoshiko Okikawa, Toshihisa Nakashima, Miki Kido
Publikováno v:
Journal of Oncology Pharmacy Practice. 18:445-447
Autor:
Toshihisa, Nakashima, Takayoshi, Kiba, Yoshikazu, Ogawa, Atsuko, Hosokawa, Hiromi, Shintani, Yuuko, Okada, Takako, Taniguchi, Masanobu, Shigeta, Kazuhiro, Kozawa
Publikováno v:
Gan to kagaku ryoho. Cancerchemotherapy. 39(9)
Were port a 51-year-old male left renal pelvic cancer patient with paclitaxel (PTX)-induced peripheral neuropathy, which was successfully treated with pregabalin. From June 2010, a gemcitabine/PTX (GP) regimen was used as third-line treatment. In ord
Autor:
Toshihisa, Nakashima, Takayoshi, Kiba, Yoshikazu, Ogawa, Akiko, Kimura, Miki, Kido, Yoshiko, Okikawa, Takuo, Ito, Akihisa, Saito, Atsuko, Hosokawa, Hiromi, Shintani, Yuko, Okada, Takako, Taniguchi, Kiyomi, Taniyama, Kazuhiro, Kozawa, Hiromasa, Niimi
Publikováno v:
Gan to kagaku ryoho. Cancerchemotherapy. 39(5)
When performing R-CHOP(rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone)for diffuse large B-cell lymphoma(DLBCL), neurotoxicity of vincristine(VCR)is the serious dose-limiting factor.Pregabalin is one of the first-line treatments